{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["density functional theory", "diabetes disease", "dipeptidyl peptidase-4 (DPP-4)", "dynamic simulations", "molecular docking", "principal component analysis"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38675143", "DateRevised": {"Year": "2024", "Month": "04", "Day": "29"}, "Article": {"Language": ["eng"], "ELocationID": ["483", "10.3390/pharmaceutics16040483"], "ArticleDate": [{"Year": "2024", "Month": "04", "Day": "01"}], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "16", "Issue": "4", "PubDate": {"Year": "2024", "Month": "Apr", "Day": "01"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study.", "Abstract": {"AbstractText": ["Diabetes, characterized by elevated blood sugar levels, poses significant health and economic risks, correlating with complications like cardiovascular disease, kidney failure, and blindness. Dipeptidyl peptidase-4 (DPP-4), also referred to as T-cell activation antigen CD26 (EC 3.4.14.5.), plays a crucial role in glucose metabolism and immune function. Inhibiting DPP-4 was anticipated as a potential new therapy for diabetes. Therefore, identification of plant-based natural inhibitors of DPP-4 would help in eradicating diabetes worldwide. Here, for the identification of the potential natural inhibitors of DPP-4, we developed a phytochemicals library consisting of over 6000 phytochemicals detected in 81 medicinal plants that exhibited anti-diabetic potency. The library has been docked against the target proteins, where isorhamnetin, Benzyl 5-Amino-5-deoxy-2,3-O-isopropyl-alpha-D-mannofuranoside (DTXSID90724586), and 5-Oxo-7-[4-(trifluoromethyl) phenyl]-4H,6H,7H-[1,2]thiazolo[4,5-b]pyridine 3-carboxylic acid (CHEMBL3446108) showed binding affinities of -8.5, -8.3, and -8.3 kcal/mol, respectively. These compounds exhibiting strong interactions with DPP-4 active sites (Glu205, Glu206, Tyr547, Trp629, Ser630, Tyr662, His740) were identified. ADME/T and bioactivity predictions affirmed their pharmacological safety. Density functional theory calculations assessed stability and reactivity, while molecular dynamics simulations demonstrated persistent stability. Analyzing parameters like RMSD, RG, RMSF, SASA, H-bonds, MM-PBSA, and FEL confirmed stable protein-ligand compound formation. Principal component analysis provided structural variation insights. Our findings suggest that those compounds might be possible candidates for developing novel inhibitors targeting DPP-4 for treating diabetes."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh."}], "LastName": "Hossain", "ForeName": "Alomgir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh."}], "LastName": "Rahman", "ForeName": "Md Ekhtiar", "Initials": "ME"}, {"Identifier": ["0000-0002-1226-7226"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Computer Science and Engineering, University of Rajshahi, Rajshahi 6205, Bangladesh."}], "LastName": "Faruqe", "ForeName": "Md Omar", "Initials": "MO"}, {"Identifier": ["0000-0002-8563-7152"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Rajshahi, Rajshahi 6205, Bangladesh."}], "LastName": "Saif", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, University of Rajshahi, Rajshahi 6205, Bangladesh."}], "LastName": "Suhi", "ForeName": "Suzzada", "Initials": "S"}, {"Identifier": ["0000-0001-6316-8829"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh."}], "LastName": "Zaman", "ForeName": "Rashed", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia."}], "LastName": "Hirad", "ForeName": "Abdurahman Hajinur", "Initials": "AH"}, {"Identifier": ["0000-0002-3594-2570"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi 6205, Bangladesh."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Gyeongsangbuk-do, Republic of Korea."}], "LastName": "Matin", "ForeName": "Mohammad Nurul", "Initials": "MN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Gyeongsangbuk-do, Republic of Korea."}], "LastName": "Rabbee", "ForeName": "Muhammad Fazle", "Initials": "MF"}, {"Identifier": ["0000-0002-6719-9187"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Gyeongsangbuk-do, Republic of Korea."}], "LastName": "Baek", "ForeName": "Kwang-Hyun", "Initials": "KH"}], "GrantList": [{"GrantID": "RSPD2024R677", "Agency": "King Saud University, Riyadh, Saudi Arabia", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Mukhtar Y., Galalain A., Yunusa U. A modern overview on diabetes mellitus: A chronic endocrine disorder. Eur. J. Biol. 2020;5:1\u201314. doi: 10.47672/ejb.409.", "ArticleIdList": ["10.47672/ejb.409"]}, {"Citation": "Chou C.-Y., Hsu D.-Y., Chou C.-H. Predicting the onset of diabetes with machine learning methods. J. Pers. Med. 2023;13:406. doi: 10.3390/jpm13030406.", "ArticleIdList": ["10.3390/jpm13030406", "PMC10057336", "36983587"]}, {"Citation": "Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B.B., Stein C., Basit A., Chan J.C.N., Mbanya J.C., et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119.", "ArticleIdList": ["10.1016/j.diabres.2021.109119", "34879977"]}, {"Citation": "Strain W.D., Pald\u00e1nius P.M. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc. Diabetol. 2018;17:57. doi: 10.1186/s12933-018-0703-2.", "ArticleIdList": ["10.1186/s12933-018-0703-2", "PMC5905152", "29669543"]}, {"Citation": "de Boer I.H., Khunti K., Sadusky T., Tuttle K.R., Neumiller J.J., Rhee C.M., Rosas S.E., Rossing P., Bakris G. Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Care. 2022;45:3075\u20133090. doi: 10.2337/dci22-0027.", "ArticleIdList": ["10.2337/dci22-0027", "PMC9870667", "36189689"]}, {"Citation": "Kropp M., Golubnitschaja O., Mazurakova A., Koklesova L., Sargheini N., Vo T.-T.K.S., de Clerck E., Polivka J., Jr., Potuznik P., Polivka J. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications\u2014Risks and mitigation. EPMA J. 2023;14:21\u201342. doi: 10.1007/s13167-023-00314-8.", "ArticleIdList": ["10.1007/s13167-023-00314-8", "PMC9971534", "36866156"]}, {"Citation": "Seuring T., Archangelidi O., Suhrcke M. The economic costs of type 2 diabetes: A global systematic review. Pharmacoeconomics. 2015;33:811\u2013831. doi: 10.1007/s40273-015-0268-9.", "ArticleIdList": ["10.1007/s40273-015-0268-9", "PMC4519633", "25787932"]}, {"Citation": "Foretz M., Guigas B., Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2019;15:569\u2013589. doi: 10.1038/s41574-019-0242-2.", "ArticleIdList": ["10.1038/s41574-019-0242-2", "31439934"]}, {"Citation": "Del Prato S., Pulizzi N. The place of sulfonylureas in the therapy for type 2 diabetes mellitus. Metabolism. 2006;55:S20\u2013S27. doi: 10.1016/j.metabol.2006.02.003.", "ArticleIdList": ["10.1016/j.metabol.2006.02.003", "16631807"]}, {"Citation": "Barnett A. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int. J. Clin. Pract. 2006;60:1454\u20131470. doi: 10.1111/j.1742-1241.2006.01178.x.", "ArticleIdList": ["10.1111/j.1742-1241.2006.01178.x", "17073841"]}, {"Citation": "Wondmkun Y.T. Obesity, insulin resistance, and type 2 diabetes: Associations and therapeutic implications. Diabetes Metab. Syndr. Obes. 2020;13:3611\u20133616. doi: 10.2147/DMSO.S275898.", "ArticleIdList": ["10.2147/DMSO.S275898", "PMC7553667", "33116712"]}, {"Citation": "Novodvorsk\u00fd P., Haluz\u00edk M. An update on the safety of insulin-GLP-1 receptor agonist combinations in type 2 diabetes mellitus. Expert Opin. Drug Saf. 2022;21:349\u2013361. doi: 10.1080/14740338.2021.1978974.", "ArticleIdList": ["10.1080/14740338.2021.1978974", "34641742"]}, {"Citation": "Dong S., Lau H., Chavarria C., Alexander M., Cimler A., Elliott J.P., Escovar S., Lewin J., Novak J., Lakey J.R.T. Effects of periodic intensive insulin therapy: An updated review. Curr. Ther. Res. 2019;90:61\u201367. doi: 10.1016/j.curtheres.2019.04.003.", "ArticleIdList": ["10.1016/j.curtheres.2019.04.003", "PMC6527898", "31193369"]}, {"Citation": "Yuan X., Wang J., Yang S., Gao M., Cao L., Li X., Hong D., Tian S., Sun C. Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: A systematic review and meta-analysis. Nutr. Diabetes. 2020;10:38. doi: 10.1038/s41387-020-00142-z.", "ArticleIdList": ["10.1038/s41387-020-00142-z", "PMC7705738", "33257645"]}, {"Citation": "Liu Y., Yang L., Zhang Y., Liu X., Wu Z., Gilbert R.G., Deng B., Wang K. Dendrobium officinale polysaccharide ameliorates diabetic hepatic glucose metabolism via glucagon-mediated signaling pathways and modifying liver-glycogen structure. J. Ethnopharmacol. 2020;248:112308. doi: 10.1016/j.jep.2019.112308.", "ArticleIdList": ["10.1016/j.jep.2019.112308", "31622745"]}, {"Citation": "Ahlqvist E., Prasad R.B., Groop L. Subtypes of type 2 diabetes determined from clinical parameters. Diabetes. 2020;69:2086\u20132093. doi: 10.2337/dbi20-0001.", "ArticleIdList": ["10.2337/dbi20-0001", "32843567"]}, {"Citation": "Fisher L., Polonsky W.H., Hessler D. Addressing diabetes distress in clinical care: A practical guide. Diabet. Med. 2019;36:803\u2013812. doi: 10.1111/dme.13967.", "ArticleIdList": ["10.1111/dme.13967", "30985025"]}, {"Citation": "Seo H., Kim M., Choi S. Diabetes management experience of middle-aged persons with type 1 diabetes. Jpn. J. Nurs. Sci. 2021;18:e12377. doi: 10.1111/jjns.12377.", "ArticleIdList": ["10.1111/jjns.12377", "32869483"]}, {"Citation": "Mattishent K., Loke Y.K. Meta-analysis: Association between hypoglycemia and serious adverse events in older patients treated with glucose-lowering agents. Front. Endocrinol. 2021;12:571568. doi: 10.3389/fendo.2021.571568.", "ArticleIdList": ["10.3389/fendo.2021.571568", "PMC7982741", "33763024"]}, {"Citation": "Iqbal J., Wu H., Hu N., Zhou Y., Li L., Xiao F., Wang T., Jiang H., Xu S., Huang B., et al. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus\u2014A systematic review and meta-analysis of randomized control trials. Obes. Rev. 2022;23:e13435. doi: 10.1111/obr.13435.", "ArticleIdList": ["10.1111/obr.13435", "35194917"]}, {"Citation": "Selby A., Reichenbach Z.W., Piech G., Friedenberg F.K. Pathophysiology, differential diagnosis, and treatment of diabetic diarrhea. Dig. Dis. Sci. 2019;64:3385\u20133393. doi: 10.1007/s10620-019-05846-6.", "ArticleIdList": ["10.1007/s10620-019-05846-6", "31541370"]}, {"Citation": "Holt R.I.G. Association between antipsychotic medication use and diabetes. Curr. Diabetes Rep. 2019;19:96. doi: 10.1007/s11892-019-1220-8.", "ArticleIdList": ["10.1007/s11892-019-1220-8", "PMC6718373", "31478094"]}, {"Citation": "Jedlowski P.M., Te C.H., Segal R.J., Fazel M.T. Cutaneous adverse effects of diabetes mellitus medications and medical devices: A review. Am. J. Clin. Dermatol. 2019;20:97\u2013114. doi: 10.1007/s40257-018-0400-7.", "ArticleIdList": ["10.1007/s40257-018-0400-7", "30361953"]}, {"Citation": "Heller S.R., Geybels M.S., Iqbal A., Liu L., Wagner L., Chow E. A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study. Diabetologia. 2022;65:55\u201364. doi: 10.1007/s00125-021-05556-7.", "ArticleIdList": ["10.1007/s00125-021-05556-7", "PMC8660716", "34704120"]}, {"Citation": "Lebovitz H.E. Thiazolidinediones: The forgotten diabetes medications. Curr. Diabetes Rep. 2019;19:151. doi: 10.1007/s11892-019-1270-y.", "ArticleIdList": ["10.1007/s11892-019-1270-y", "PMC6881429", "31776781"]}, {"Citation": "Kalhotra P., Chittepu V.C.S.R., Osorio-Revilla G., Gallardo-Vel\u00e1zquez T. Discovery of galangin as a potential DPP-4 inhibitor that improves insulin-stimulated skeletal muscle glucose uptake: A combinational therapy for diabetes. Int. J. Mol. Sci. 2019;20:1228. doi: 10.3390/ijms20051228.", "ArticleIdList": ["10.3390/ijms20051228", "PMC6429117", "30862104"]}, {"Citation": "Yoon H., Sung J.H., Song M.J. Effects of the antidiabetic drugs evogliptin and sitagliptin on the immune function of CD26/DPP4 in Th1 cells. Biomol. Ther. 2021;29:154. doi: 10.4062/biomolther.2020.150.", "ArticleIdList": ["10.4062/biomolther.2020.150", "PMC7921863", "33148870"]}, {"Citation": "Gao Y., Zhang Y., Zhu J., Li B., Li Z., Zhu W., Shi J., Jia Q., Li Y. Recent progress in natural products as DPP-4 inhibitors. Future Med. Chem. 2015;7:1079\u20131089. doi: 10.4155/fmc.15.49.", "ArticleIdList": ["10.4155/fmc.15.49", "26062402"]}, {"Citation": "Zhang K.-W., Liu S.-Y., Jia Y., Zou M.-L., Teng Y.-Y., Chen Z.-H., Li Y., Guo D., Wu J.-J., Yuan Z.-D., et al. Insight into the role of DPP-4 in fibrotic wound healing. Biomed. Pharmacother. 2022;151:113143. doi: 10.1016/j.biopha.2022.113143.", "ArticleIdList": ["10.1016/j.biopha.2022.113143", "35643071"]}, {"Citation": "Eckhardt M., Langkopf E., Mark M., Tadayyon M., Thomas L., Nar H., Pfrengle W., Guth B., Lotz R., Sieger P., et al. 8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin- 2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. J. Med. Chem. 2007;50:6450\u20136453. doi: 10.1021/jm701280z.", "ArticleIdList": ["10.1021/jm701280z", "18052023"]}, {"Citation": "Kumar S., Mittal A., Mittal A. A review upon medicinal perspective and designing rationale of DPP-4 inhibitors. Bioorganic Med. Chem. 2021;46:116354. doi: 10.1016/j.bmc.2021.116354.", "ArticleIdList": ["10.1016/j.bmc.2021.116354", "34428715"]}, {"Citation": "Peters J.-U. 11 years of cyanopyrrolidines as DPP-IV inhibitors. Curr. Top. Med. Chem. 2007;7:579\u2013595. doi: 10.2174/156802607780091000.", "ArticleIdList": ["10.2174/156802607780091000", "17352679"]}, {"Citation": "Metzler W.J., Yanchunas J., Weigelt C., Kish K., Klei H.E., Xie D., Zhang Y., Corbett M., Tamura J.K., He B. Involvement of DPP-IV catalytic residues in enzyme\u2013saxagliptin complex formation. Protein Sci. 2008;17:240\u2013250. doi: 10.1110/ps.073253208.", "ArticleIdList": ["10.1110/ps.073253208", "PMC2222712", "18227430"]}, {"Citation": "Ahr\u00e9n B., Schmitz O. GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes. Horm. Metab. Res. 2004;36:867\u2013876. doi: 10.1055/s-2004-826178.", "ArticleIdList": ["10.1055/s-2004-826178", "15655721"]}, {"Citation": "Sternkopf M., Nagy M., Baaten C.C., Kuijpers M.J.E., Tullemans B.M.E., Wirth J., Theelen W., Mastenbroek T.G., Lehrke M., Winnerling B., et al. Native, intact glucagon-like peptide 1 is a natural suppressor of thrombus growth under physiological flow conditions. Arterioscler. Thromb. Vasc. Biol. 2020;40:e65\u2013e77. doi: 10.1161/ATVBAHA.119.313645.", "ArticleIdList": ["10.1161/ATVBAHA.119.313645", "31893947"]}, {"Citation": "Fisman E.Z., Tenenbaum A. The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: A novel cardiometabolic therapeutic prospect. Cardiovasc. Diabetol. 2021;20:225. doi: 10.1186/s12933-021-01412-5.", "ArticleIdList": ["10.1186/s12933-021-01412-5", "PMC8613929", "34819089"]}, {"Citation": "Thomas M.K., Nikooienejad A., Bray R., Cui X., Wilson J., Duffin K., Milicevic Z., Haupt A., Robins D.A. Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes. J. Clin. Endocrinol. Metab. 2021;106:388\u2013396. doi: 10.1210/clinem/dgaa863.", "ArticleIdList": ["10.1210/clinem/dgaa863", "PMC7823251", "33236115"]}, {"Citation": "Gilbert M.P., Pratley R.E. GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: Review of head-to-head clinical trials. Front. Endocrinol. 2020;11:178. doi: 10.3389/fendo.2020.00178.", "ArticleIdList": ["10.3389/fendo.2020.00178", "PMC7145895", "32308645"]}, {"Citation": "Pinheiro M.M., Fabbri A., Infante M. Cytokine storm modulation in COVID-19: A proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i) Immunotherapy. 2021;13:753\u2013765. doi: 10.2217/imt-2020-0349.", "ArticleIdList": ["10.2217/imt-2020-0349", "PMC8080872", "33906375"]}, {"Citation": "Wilson A.L., Moffitt L.R., Wilson K.L., Bilandzic M., Wright M.D., Gorrell M.D., Oehler M.K., Plebanski M., Stephens A.N. DPP4 inhibitor sitagliptin enhances lymphocyte recruitment and prolongs survival in a syngeneic ovarian cancer mouse model. Cancers. 2021;13:487. doi: 10.3390/cancers13030487.", "ArticleIdList": ["10.3390/cancers13030487", "PMC7865851", "33513866"]}, {"Citation": "Scheen A.J. DPP-4 inhibition and COVID-19: From initial concerns to recent expectations. Diabetes Metab. 2021;47:101213. doi: 10.1016/j.diabet.2020.11.005.", "ArticleIdList": ["10.1016/j.diabet.2020.11.005", "PMC7690941", "33249199"]}, {"Citation": "Razavi M., Wei Y.-Y., Rao X.-Q., Zhong J.-X. DPP-4 inhibitors and GLP-1RAs: Cardiovascular safety and benefits. Mil. Med. Res. 2022;9:45. doi: 10.1186/s40779-022-00410-2.", "ArticleIdList": ["10.1186/s40779-022-00410-2", "PMC9392232", "35986429"]}, {"Citation": "Ng L., Foo D.C.-C., Wong C.K.-H., Man A.T.-K., Lo O.S.-H., Law W.-L. Repurposing DPP-4 inhibitors for colorectal cancer: A retrospective and single center study. Cancers. 2021;13:3588. doi: 10.3390/cancers13143588.", "ArticleIdList": ["10.3390/cancers13143588", "PMC8306906", "34298800"]}, {"Citation": "Bagherniya M., Khedmatgozar H., Fakheran O., Xu S., Johnston T.P., Sahebkar A. Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome. Phytother. Res. 2021;35:4804\u20134833. doi: 10.1002/ptr.7118.", "ArticleIdList": ["10.1002/ptr.7118", "33856730"]}, {"Citation": "Kooti W., Farokhipour M., Asadzadeh Z., Ashtary-Larky D., Asadi-Samani M. The role of medicinal plants in the treatment of diabetes: A systematic review. Electron. Physician. 2016;8:1832\u20131842. doi: 10.19082/1832.", "ArticleIdList": ["10.19082/1832", "PMC4768936", "26955456"]}, {"Citation": "Rao K., Giri R., Kesavulu M.M., Apparao C. Herbal medicine in the management of diabetes mellitus. Manphar Vaidhya Patrica. 1997;1:33\u201335."}, {"Citation": "Chhabria S., Mathur S., Vadakan S., Sahoo D.K., Mishra P., Paital B. A review on phytochemical and pharmacological facets of tropical ethnomedicinal plants as reformed DPP-IV inhibitors to regulate incretin activity. Front. Endocrinol. 2022;13:1027237. doi: 10.3389/fendo.2022.1027237.", "ArticleIdList": ["10.3389/fendo.2022.1027237", "PMC9691845", "36440220"]}, {"Citation": "Singh A.-K., Patel P.K., Choudhary K., Joshi J., Yadav D., Jin J.-O. Quercetin and coumarin inhibit dipeptidyl peptidase-IV and exhibits antioxidant properties: In silico, in vitro, ex vivo. Biomolecules. 2020;10:207. doi: 10.3390/biom10020207.", "ArticleIdList": ["10.3390/biom10020207", "PMC7072504", "32023875"]}, {"Citation": "Ansari P., Choudhury S.T., Seidel V., Bin Rahman A., Aziz M.A., Richi A.E., Rahman A., Jafrin U.H., Hannan J.M.A., Abdel-Wahab Y.H.A. Therapeutic potential of quercetin in the management of type-2 diabetes mellitus. Life. 2022;12:1146. doi: 10.3390/life12081146.", "ArticleIdList": ["10.3390/life12081146", "PMC9409999", "36013325"]}, {"Citation": "Li M., Bao X., Zhang X., Ren H., Cai S., Hu X., Yi J. Exploring the phytochemicals and inhibitory effects against \u03b1-glucosidase and dipeptidyl peptidase-IV in Chinese pickled chili pepper: Insights into mechanisms by molecular docking analysis. LWT. 2022;162:113467. doi: 10.1016/j.lwt.2022.113467.", "ArticleIdList": ["10.1016/j.lwt.2022.113467"]}, {"Citation": "Kong M., Xie K., Lv M., Li J., Yao J., Yan K., Wu X., Xu Y., Ye D. Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise. Biomed. Pharmacother. 2021;133:110975. doi: 10.1016/j.biopha.2020.110975.", "ArticleIdList": ["10.1016/j.biopha.2020.110975", "33212375"]}, {"Citation": "Bacanli M., Dilsiz S.A., Ba\u015faran N., Ba\u015faran A.A. Effects of phytochemicals against diabetes. Adv. Food Nutr. Res. 2019;89:209\u2013238.", "ArticleIdList": ["31351526"]}, {"Citation": "Cote B., Elbarbry F., Bui F., Su J.W., Seo K., Nguyen A., Lee M., Rao D.A. Mechanistic basis for the role of phytochemicals in inflammation-associated chronic diseases. Molecules. 2022;27:781. doi: 10.3390/molecules27030781.", "ArticleIdList": ["10.3390/molecules27030781", "PMC8838908", "35164043"]}, {"Citation": "Shaikh S., Lee E.-J., Ahmad K., Ahmad S.-S., Lim J.-H., Choi I. A comprehensive review and perspective on natural sources as dipeptidyl peptidase-4 inhibitors for management of diabetes. Pharmaceuticals. 2021;14:591. doi: 10.3390/ph14060591.", "ArticleIdList": ["10.3390/ph14060591", "PMC8235117", "34203048"]}, {"Citation": "Han D.-G., Cho S.-S., Kwak J.-H., Yoon I.-S. Medicinal plants and phytochemicals for diabetes mellitus: Pharmacokinetic characteristics and herb-drug interactions. J. Pharm. Investig. 2019;49:603\u2013612. doi: 10.1007/s40005-019-00440-4.", "ArticleIdList": ["10.1007/s40005-019-00440-4"]}, {"Citation": "Shanak S., Bassalat N., Barghash A., Kadan S., Ardah M., Zaid H. Drug discovery of plausible lead natural compounds that target the insulin signaling pathway: Bioinformatics approaches. Evid.-Based Complement. Altern. Med. 2022;2022:2832889. doi: 10.1155/2022/2832889.", "ArticleIdList": ["10.1155/2022/2832889", "PMC8958086", "35356248"]}, {"Citation": "Najmi A., Javed S.A., Al Bratty M., Alhazmi H.A. Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents. Molecules. 2022;27:349. doi: 10.3390/molecules27020349.", "ArticleIdList": ["10.3390/molecules27020349", "PMC8779633", "35056662"]}, {"Citation": "Eissa I.H., Yousef R.G., Asmaey M.A., Elkady H., Husein D.Z., Alsfouk A.A., Ibrahim I.M., Elkady M.A., Elkaeed E.B., Metwaly A.M. Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2. Saudi Pharm. J. 2023;31:101852. doi: 10.1016/j.jsps.2023.101852.", "ArticleIdList": ["10.1016/j.jsps.2023.101852", "PMC10663924", "38028225"]}, {"Citation": "Yang X., Wang Y., Byrne R., Schneider G., Yang S. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery. Chem. Rev. 2019;119:10520\u201310594. doi: 10.1021/acs.chemrev.8b00728.", "ArticleIdList": ["10.1021/acs.chemrev.8b00728", "31294972"]}, {"Citation": "Elton D.C., Boukouvalas Z., Fuge M.D., Chung P.W. Deep learning for molecular design\u2014A review of the state of the art. Mol. Syst. Des. Eng. 2019;4:828\u2013849. doi: 10.1039/C9ME00039A.", "ArticleIdList": ["10.1039/C9ME00039A"]}, {"Citation": "Ferreira L.L.G., Andricopulo A.D. ADMET modeling approaches in drug discovery. Drug Discov. Today. 2019;24:1157\u20131165. doi: 10.1016/j.drudis.2019.03.015.", "ArticleIdList": ["10.1016/j.drudis.2019.03.015", "30890362"]}, {"Citation": "Fan J., Fu A., Zhang L. Progress in molecular docking. Quant. Biol. 2019;7:83\u201389. doi: 10.1007/s40484-019-0172-y.", "ArticleIdList": ["10.1007/s40484-019-0172-y"]}, {"Citation": "Pouliot M., Jeanmart S. Pan Assay Interference Compounds (PAINS) and other promiscuous compounds in antifungal research: Miniperspective. J. Med. Chem. 2016;59:497\u2013503. doi: 10.1021/acs.jmedchem.5b00361.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00361", "26313340"]}, {"Citation": "Pinzi L., Rastelli G. Molecular docking: Shifting paradigms in drug discovery. Int. J. Mol. Sci. 2019;20:4331. doi: 10.3390/ijms20184331.", "ArticleIdList": ["10.3390/ijms20184331", "PMC6769923", "31487867"]}, {"Citation": "Halgren T.A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 1996;17:490\u2013519. doi: 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P.", "ArticleIdList": ["10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P"]}, {"Citation": "Dallakyan S., Olson A.J. Small-molecule library screening by docking with PyRx. Chem. Biol. Methods Protoc. 2015;1263:243\u2013250.", "ArticleIdList": ["25618350"]}, {"Citation": "Case D.A., Babin V., Berryman J.T., Betz R.M., Cai Q., Cerutti D.S., Cheatham T.E., Darden T.A., Duke R.E., Gohlke H., et al. AMBER 14. University of California; San Francisco, CA, USA: 2014."}, {"Citation": "Krieger E., Vriend G., Spronk C. YASARA\u2013yet another scientific artificial reality application. YASARA Org. 2013;993:51\u201378."}, {"Citation": "Hossain A., Rahman M.E., Rahman M.S., Nasirujjaman K., Matin M.N., Faruqe M.O., Rabbee M.F. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (Mpro) using molecular docking and deep learning methods. Comput. Biol. Med. 2023;157:106785. doi: 10.1016/j.compbiomed.2023.106785.", "ArticleIdList": ["10.1016/j.compbiomed.2023.106785", "PMC10008098", "36931201"]}, {"Citation": "Banerjee P., Eckert A.O., Schrey A.K., Preissner R. ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46:W257\u2013W263. doi: 10.1093/nar/gky318.", "ArticleIdList": ["10.1093/nar/gky318", "PMC6031011", "29718510"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Pires D.E.V., Blundell T.L., Ascher D.B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 2015;58:4066\u20134072. doi: 10.1021/acs.jmedchem.5b00104.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}, {"Citation": "Frisch A. Gaussian 09W Reference. Volume 470. Gaussian, Inc.; Wallingford, CT, USA: 2009. 25p"}, {"Citation": "Tirado-Rives J., Jorgensen W.L. Performance of B3LYP density functional methods for a large set of organic molecules. J. Chem. Theory Comput. 2008;4:297\u2013306. doi: 10.1021/ct700248k.", "ArticleIdList": ["10.1021/ct700248k", "26620661"]}, {"Citation": "Legler C.R., Brown N.R., Dunbar R.A., Harness M.D., Nguyen K., Oyewole O., Collier W.B. Scaled quantum mechanical scale factors for vibrational calculations using alternate polarized and augmented basis sets with the B3LYP density functional calculation model. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2015;145:15\u201324. doi: 10.1016/j.saa.2015.02.103.", "ArticleIdList": ["10.1016/j.saa.2015.02.103", "25766474"]}, {"Citation": "Karplus M., Petsko G.A. Molecular dynamics simulations in biology. Nature. 1990;347:631\u2013639. doi: 10.1038/347631a0.", "ArticleIdList": ["10.1038/347631a0", "2215695"]}, {"Citation": "Krieger E., Nielsen J.E., Spronk C.A.E.M., Vriend G. Fast empirical pKa prediction by Ewald summation. J. Mol. Graph. Model. 2006;25:481\u2013486. doi: 10.1016/j.jmgm.2006.02.009.", "ArticleIdList": ["10.1016/j.jmgm.2006.02.009", "16644253"]}, {"Citation": "Sagui C., Darden T.A. Molecular dynamics simulations of biomolecules: Long-range electrostatic effects. Annu. Rev. Biophys. Biomol. Struct. 1999;28:155\u2013179. doi: 10.1146/annurev.biophys.28.1.155.", "ArticleIdList": ["10.1146/annurev.biophys.28.1.155", "10410799"]}, {"Citation": "Lippert R.A., Predescu C., Ierardi D.J., Mackenzie K.M., Eastwood M.P., Dror R.O., Shaw D.E. Accurate and efficient integration for molecular dynamics simulations at constant temperature and pressure. J. Chem. Phys. 2013;139:164106. doi: 10.1063/1.4825247.", "ArticleIdList": ["10.1063/1.4825247", "24182003"]}, {"Citation": "Collier T.A., Piggot T.J., Allison J.R. Molecular dynamics simulation of proteins. In: Gerrard J., Domigan L., editors. Protein Nanotechnology. Methods in Molecular Biology. Volume 2073. Humana; New York, NY, USA: 2020. pp. 311\u2013327.", "ArticleIdList": ["31612449"]}, {"Citation": "Mahmud S., Paul G.K., Biswas S., Afrose S., Mita M.A., Hasan M.R., Shimu M.S.S., Hossain A., Promi M.M., Ema F.K., et al. Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2. Front. Mol. Biosci. 2021;8:628585. doi: 10.3389/fmolb.2021.628585.", "ArticleIdList": ["10.3389/fmolb.2021.628585", "PMC8142691", "34041263"]}, {"Citation": "Dutta M., Tareq A.M., Rakib A., Mahmud S., Sami S.A., Mallick J., Islam M.N., Majumder M., Uddin Z., Alsubaie A., et al. Phytochemicals from Leucas zeylanica Targeting Main Protease of SARS-CoV-2: Chemical Profiles, Molecular Docking, and Molecular Dynamics Simulations. Biology. 2021;10:789. doi: 10.3390/biology10080789.", "ArticleIdList": ["10.3390/biology10080789", "PMC8389631", "34440024"]}, {"Citation": "Homeyer N., Gohlke H. Free energy calculations by the molecular mechanics Poisson\u2212 Boltzmann surface area method. Mol. Inform. 2012;31:114\u2013122. doi: 10.1002/minf.201100135.", "ArticleIdList": ["10.1002/minf.201100135", "27476956"]}, {"Citation": "Hou T., Wang J., Li Y., Wang W. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. The accuracy of ranking poses generated from docking. J. Comput. Chem. 2011;32:866\u2013877. doi: 10.1002/jcc.21666.", "ArticleIdList": ["10.1002/jcc.21666", "PMC3043139", "20949517"]}, {"Citation": "Encinar J.A., Menendez J.A. Potential drugs targeting early innate immune evasion of SARS-coronavirus 2 via 2\u2032-O-methylation of viral RNA. Viruses. 2020;12:525. doi: 10.3390/v12050525.", "ArticleIdList": ["10.3390/v12050525", "PMC7291090", "32397643"]}, {"Citation": "Jonniya N.A., Zhang J., Kar P. Molecular Mechanism of Inhibiting WNK Binding to OSR1 by Targeting the Allosteric Pocket of the OSR1-CCT Domain with Potential Antihypertensive Inhibitors: An In Silico Study. J. Phys. Chem. B. 2021;125:9115\u20139129. doi: 10.1021/acs.jpcb.1c04672.", "ArticleIdList": ["10.1021/acs.jpcb.1c04672", "34369793"]}, {"Citation": "Nazar A., Abbas G., Azam S.S. Deciphering the Inhibition Mechanism of under Trial Hsp90 Inhibitors and Their Analogues: A Comparative Molecular Dynamics Simulation. J. Chem. Inf. Model. 2020;60:3812\u20133830. doi: 10.1021/acs.jcim.9b01134.", "ArticleIdList": ["10.1021/acs.jcim.9b01134", "32659088"]}, {"Citation": "Rampogu S., Gajula R.G., Lee G., Kim M.O., Lee K.W. Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape. Comput. Biol. Med. 2021;135:104525. doi: 10.1016/j.compbiomed.2021.104525.", "ArticleIdList": ["10.1016/j.compbiomed.2021.104525", "PMC8164349", "34252682"]}, {"Citation": "Maisuradze G.G., Liwo A., Scheraga H.A. Relation between free energy landscapes of proteins and dynamics. J. Chem. Theory Comput. 2010;6:583\u2013595. doi: 10.1021/ct9005745.", "ArticleIdList": ["10.1021/ct9005745", "PMC3633568", "23620713"]}, {"Citation": "Papaleo E., Mereghetti P., Fantucci P., Grandori R., De Gioia L. Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: The myoglobin case. J. Mol. Graph. Model. 2009;27:889\u2013899. doi: 10.1016/j.jmgm.2009.01.006.", "ArticleIdList": ["10.1016/j.jmgm.2009.01.006", "19264523"]}, {"Citation": "Altis A., Nguyen P.H., Hegger R., Stock G. Dihedral angle principal component analysis of molecular dynamics simulations. J. Chem. Phys. 2007;126:244111. doi: 10.1063/1.2746330.", "ArticleIdList": ["10.1063/1.2746330", "17614541"]}, {"Citation": "Blows M.W. A tale of two matrices: Multivariate approaches in evolutionary biology. J. Evol. Biol. 2007;20:1\u20138. doi: 10.1111/j.1420-9101.2006.01164.x.", "ArticleIdList": ["10.1111/j.1420-9101.2006.01164.x", "17209986"]}, {"Citation": "Jairajpuri D.S., Hussain A., Nasreen K., Mohammad T., Anjum F., Rehman M.T., Hasan G.M., Alajmi M.F., Hassan M.I. Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations. Saudi J. Biol. Sci. 2021;28:2423\u20132431. doi: 10.1016/j.sjbs.2021.01.040.", "ArticleIdList": ["10.1016/j.sjbs.2021.01.040", "PMC7839507", "33526965"]}, {"Citation": "Duttaroy A., Voelker F., Merriam K., Zhang X., Ren X., Subramanian K., Hughes T.E., Burkey B.F. The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats. Eur. J. Pharmacol. 2011;650:703\u2013707. doi: 10.1016/j.ejphar.2010.10.062.", "ArticleIdList": ["10.1016/j.ejphar.2010.10.062", "21070766"]}, {"Citation": "Krishnan S.R., Bung N., Bulusu G., Roy A. Accelerating de novo drug design against novel proteins using deep learning. J. Chem. Inf. Model. 2021;61:621\u2013630. doi: 10.1021/acs.jcim.0c01060.", "ArticleIdList": ["10.1021/acs.jcim.0c01060", "33491455"]}, {"Citation": "Gong G., Guan Y.Y., Zhang Z.L., Rahman K., Wang S.J., Zhou S., Luan X., Zhang H. Isorhamnetin: A review of pharmacological effects. Biomed. Pharmacother. 2020;128:110301. doi: 10.1016/j.biopha.2020.110301.", "ArticleIdList": ["10.1016/j.biopha.2020.110301", "32502837"]}, {"Citation": "Teng D., Luan X. Research progress of isorhamnetin in pharma codynamics. J. Tradit. Chin. Med. Sci. 2016;28:593\u2013596."}, {"Citation": "Sutton J.M., Clark D.E., Dunsdon S.J., Fenton G., Fillmore A., Harris N.V., Higgs C., Hurley C.A., Krintel S.L., MacKenzie R.E., et al. Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes. Bioorg. Med. Chem. Lett. 2012;22:1464\u20131468. doi: 10.1016/j.bmcl.2011.11.054.", "ArticleIdList": ["10.1016/j.bmcl.2011.11.054", "22177783"]}, {"Citation": "Sajal H., Patil S.M., Raj R., Shbeer A.M., Ageel M., Ramu R. Computer-Aided Screening of Phytoconstituents from Ocimum tenuiflorum against Diabetes Mellitus Targeting DPP4 Inhibition: A Combination of Molecular Docking, Molecular Dynamics, and Pharmacokinetics Approaches. Molecules. 2022;27:5133. doi: 10.3390/molecules27165133.", "ArticleIdList": ["10.3390/molecules27165133", "PMC9415412", "36014373"]}, {"Citation": "Yang Y., Shi C.-Y., Xie J., Dai J.-H., He S.-L., Tian Y. Identification of Potential Dipeptidyl Peptidase. Molecules. 2020;25:189. doi: 10.3390/molecules25010189.", "ArticleIdList": ["10.3390/molecules25010189", "PMC6983023", "31906524"]}, {"Citation": "Ursu O., Rayan A., Goldblum A., Oprea T.I. Understanding drug-likeness. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2011;1:760\u2013781. doi: 10.1002/wcms.52.", "ArticleIdList": ["10.1002/wcms.52"]}, {"Citation": "Wang Y., Xing J., Xu Y., Zhou N., Peng J., Xiong Z., Liu X., Luo X., Luo C., Chen K., et al. In silico ADME/T modelling for rational drug design. Q. Rev. Biophys. 2015;48:488\u2013515. doi: 10.1017/S0033583515000190.", "ArticleIdList": ["10.1017/S0033583515000190", "26328949"]}, {"Citation": "Hosseini A., Gharibi T., Marofi F., Javadian M., Babaloo Z., Baradaran B. Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases. J. Cell. Physiol. 2020;235:5903\u20135924. doi: 10.1002/jcp.29593.", "ArticleIdList": ["10.1002/jcp.29593", "32072644"]}, {"Citation": "Sargsyan K., Grauffel C., Lim C. How molecular size impacts RMSD applications in molecular dynamics simulations. J. Chem. Theory Comput. 2017;13:1518\u20131524. doi: 10.1021/acs.jctc.7b00028.", "ArticleIdList": ["10.1021/acs.jctc.7b00028", "28267328"]}, {"Citation": "Kumari R., Kumar R., Consortium O.S.D.D., Lynn A. g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 2014;54:1951\u20131962. doi: 10.1021/ci500020m.", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "Ozalp L., Erdem S.S., Y\u00fcce-Dursun B., Mutlu \u00d6., \u00d6zbil M. Computational insight into the phthalocyanine-DNA binding via docking and molecular dynamics simulations. Comput. Biol. Chem. 2018;77:87\u201396. doi: 10.1016/j.compbiolchem.2018.09.009.", "ArticleIdList": ["10.1016/j.compbiolchem.2018.09.009", "30245350"]}, {"Citation": "Jakub\u00edk J., Rand\u00e1kov\u00e1 A., Dole\u017eal V. On homology modeling of the M 2 muscarinic acetylcholine receptor subtype. J. Comput-Aided Mol. Des. 2013;27:525\u2013538. doi: 10.1007/s10822-013-9660-8.", "ArticleIdList": ["10.1007/s10822-013-9660-8", "PMC3717152", "23812908"]}, {"Citation": "Khan M.T., Khan A., Rehman A.U., Wang Y., Akhtar K., Malik S.I., Wei D.-Q. Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance. Sci. Rep. 2019;9:7482. doi: 10.1038/s41598-019-44013-9.", "ArticleIdList": ["10.1038/s41598-019-44013-9", "PMC6522564", "31097767"]}, {"Citation": "David C.C., Jacobs D.J. Principal component analysis: A method for determining the essential dynamics of proteins. Protein Dyn. Methods Protoc. 2014;1084:193\u2013226.", "ArticleIdList": ["PMC4676806", "24061923"]}, {"Citation": "Sporns O., Tononi G., Edelman G.M. Theoretical neuroanatomy: Relating anatomical and functional connectivity in graphs and cortical connection matrices. Cereb. Cortex. 2000;10:127\u2013141. doi: 10.1093/cercor/10.2.127.", "ArticleIdList": ["10.1093/cercor/10.2.127", "10667981"]}]}], "History": [{"Year": "2024", "Month": "2", "Day": "19"}, {"Year": "2024", "Month": "3", "Day": "20"}, {"Year": "2024", "Month": "3", "Day": "27"}, {"Year": "2024", "Month": "4", "Day": "27", "Hour": "9", "Minute": "52"}, {"Year": "2024", "Month": "4", "Day": "27", "Hour": "9", "Minute": "51"}, {"Year": "2024", "Month": "4", "Day": "27", "Hour": "1", "Minute": "21"}, {"Year": "2024", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["38675143", "PMC11053753", "10.3390/pharmaceutics16040483", "pharmaceutics16040483"]}}]}